Extending higher dosage of etanercept found safe.(Dermatologic Theraphy)
Publication: Skin & Allergy News
Publication Date: 01-SEP-05
Author: Wendling, Patrice
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
CHICAGO--Maintaining patients with moderate to severe psoriasis on a higher than recommended dose of etanercept is safe, according to new long-term multi-center phase III data.
Whereas the recommended dosing in the United States is for 3 months of 50 mg etanercept twice weekly followed by a reduction to a maintenance dose of 50 mg per week, the current analysis evaluated 50 mg twice weekly through 48 weeks.
The study reflects the off-label use of etanercept (Enbrel) by dermatologists...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
